Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 40 | 23 | N/A |
| Accounts receivable | 428 | -63 | -263 |
| Accounts payable and accrued liabilities | 500 | 27 | 0 |
| Other Working Capital | 474 | -127 | 125 |
| Other Operating Activity | -5,129 | -2,575 | -771 |
| Operating Cash Flow | $-3,687 | $-2,715 | $-909 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -9 | -3 |
| Investing Cash Flow | $0 | $-9 | $-3 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -39 | -38 | 0 |
| Common Stock Issued | 3,624 | 4,492 | 1,118 |
| Other Financing Activity | 439 | 0 | 0 |
| Financing Cash Flow | $4,024 | $4,454 | $1,118 |
| Exchange Rate Effect | 28 | 29 | 2 |
| Beginning Cash Position | 1,973 | 214 | 6 |
| End Cash Position | 2,338 | 1,973 | 214 |
| Net Cash Flow | $337 | $1,730 | $206 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,687 | -2,715 | -909 |
| Capital Expenditure | N/A | -9 | -3 |
| Free Cash Flow | -3,687 | -2,724 | -912 |